ClinConnect ClinConnect Logo
Search / Trial NCT06991881

Eosinophilic Esophagitis: Towards Improved Management

Launched by OSLO UNIVERSITY HOSPITAL · May 27, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on improving the care and management of eosinophilic esophagitis, a condition that affects the esophagus and can cause difficulty swallowing and other symptoms. The trial is being conducted in collaboration with pediatric units in Norway and aims to explore new and existing tests that can help doctors diagnose and monitor the condition without needing as many invasive procedures, like endoscopies. This means that children and teenagers could spend less time on strict diets and have a more comfortable experience managing their condition.

To participate in this trial, individuals must either have a confirmed diagnosis of eosinophilic esophagitis or have symptoms that suggest they might have it. The trial is open to all genders and is currently recruiting participants. It is important to note that those with serious chronic health issues that would make anesthesia unsafe, or who do not give consent, will not be eligible to take part. Participants can expect to engage in a study that aims to make living with eosinophilic esophagitis easier and more manageable.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • a diagnosis of eosinophilic esophagitis
  • suspected but not yet confirmed eosinophilic esophagitis
  • Exclusion Criteria:
  • chronic severe conditions that preclude general anaestesia
  • lack of consent

About Oslo University Hospital

Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.

Locations

Bergen, , Norway

Oslo, , Norway

Patients applied

0 patients applied

Trial Officials

Ketil Størdal, PhD

Principal Investigator

University of Oslo

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported